Xiaopeng Peng

5PUBLICATIONS
2CO-AUTHORS
Molecular medicineMolecular targetsPharmacogenomicsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2025
Correction to "Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities".

Shuqing Li, Wanyi Pan, Chengpeng Tao

|Apr 15, 2025
Discovery of Dual PD-L1/HDAC3 Inhibitors for Tumor Immunotherapy.

Zhijie Wang, HaiQi He, Xiaotong Liao

|Feb 20, 2025
Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy.

Zhihao Hu, Shuqing Li, Haiqi He

|Jan 28, 2025
Discovery of Highly Potent and Orally Bioavailable Histone Deacetylase 3 Inhibitors as Immunomodulators and Enhancers of DNA-Damage Response in Cancer Therapy.

Shuqing Li, Zhihao Hu, Wanyi Pan

|Jan 23, 2025
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy.

Zhiqiang Sun, Jinmei Cheng, Chenglong Xu

Pageof 1

Frequent Collaborators

4 joint publications

Jianjun Chen

2 joint publications

Binbin Cheng